Since the initial work of Gale (5, 6) , it is well known that the transport of amino acids into the bacterial cell occurs by physical diffusion or by an active process requiring specific membrane proteins and the generation of energy. Although many workers (17) (18) (19) 24) have studied the transport of amino acids in mycobacteria, no report on the effect of antituberculous drugs on such transport appears to be available. Some of these drugs may inhibit amino acid transport by a primary or a secondary effect. D-Cycloserine, for example, owes its bactericidal action to its ability to inhibit the incorporation of alanine into the bacterial cell wall (16) . The present investigation was undertaken in view of the paucity of essential information on the effect of antituberculous drugs on the uptake of amino acids.
Because differences exist between various species of mycobacteria, the pathogenic H37Rv strain of Mycobacterium tuberculosis, which causes the disease in man, was selected for uptake studies. Here again, the in vitro-grown bacillus has been shown to be different in chemical composition and staining properties from the in vivo-grown bacillus (12, 20, 21) . Hence, in addition to in vitro-grown tubercle bacilli, bacilli isolated from tuberculous mouse lung in vivo were also employed in the present investigation.
If the endogenous level of the amino acid is very low because of rapid metabolic conversion to other products, determination of its initial rate of upake and a study of the kinetics involved pose difficulties. Therefore, it is not possible to study the kinetics of transport of all amino acids. In the present investigation, tryptophan, one of the aromatic amino acids, which is not attacked by any strain of mycobacteria (7), was selected. Kinetics of tryptophan uptake and the effect of rifampin and ethambutol are discussed in this paper. Isolation of in vivo-grown bacilli. Adult, bacteria-susceptible albino mice of either sex were injected intraperitoneally with 5 mg of virulent M. tuberculosis H37Rv grown in a modified Sauton medium containing Tween 80 and bovine serum albumin fraction V (22) . The culture was shaken continuously and was 10 days old. After 3 weeks of infection, the mice were sacrificed, and the tuberculous lungs were removed and stored at 0°C until a sufficient amount of the tissue was available for the isolation of in vivo bacilli. In vivo-grown bacilli were isolated by the method of Kanai (9) with a slight modification. The third step of centrifugation of the supernatant was repeated for 10 min again at 1,000 rpm (International Equipment Co., Refrigerated centrifuge model B-20). This gave a purer collection of acid-fast bacilli without any blue-stained tissue debris, although the yield was reduced from 1 to 0.8 mg of bacilli per infected mouse lung. The bacilli were suspended in the same nitrogen-free medium containing Tween 80 as for in vitro-grown bacilli, and the cell density was adjusted to 1 mg/ml (dry weight). was added, and 1-ml portions of the cell suspension were removed at various time intervals and filtered through filters (Millipore Corp.; pore size, 0.45 pm). Filter disks containing bacilli were washed with 10 ml of the same medium in which they were suspended and dried. Scintillation fluid was added to glass vials containing dried samples, and radioactivity was assayed with a model LS-233 Beckman liquid scintillation counter. The scintillation fluid contained 4 g of 2,5-diphenyloxazole and 0.20 g of 1,4-bis-2-(5-phenoxazolyl)benzene per liter of toluene.
MATERIALS AND METHODS
For kinetic studies, different concentrations of labeled tryptophan were used. Minimal inhibitory concentrations of Rifampin and ethambutol were added along with tryptophan, and uptake was studied. After 10 min of preincubation with sodium azide (2 mmol), labeled tryptophan was added, and uptake was studied in the same way. Figures 1 and 2 clearly indicate that a transport system existed for tryptophan in both in vitro-and in vivo-grown tubercle bacilli. The Km was 10 tifnes higher than that reported for M. phlei (19) , indicating low affinity. Bacilli grown under in vivo conditions had more affinity for tryptophan than those grown in vitro ( 4). Sodium azide effectively prevented tryptophan uptake in both the cases (Fig. 5 and 6 ), implying that generation of energy is necessary for the process. However, the possibility of a small amount of amino acid entering the cells by simple diffusion cannot be ruled out. In M. phlei sodium azide also has been shown to inhibit tryptophan uptake (19) . The minimal inhibitory concentration of rifampin (0.5 pg/ml) has no effect on the uptake, although a slight fall was seen after 10 min ( Fig.  7 and 8 ). Rifampin is a specific inhibitor of the not  FIG. 4 . KineticsofDL-pH]tryptophan uptake n incorporated into the protein. Because tryptoivo-grown tubercle bacilli. Details were the same cs phan is also not metabolized inside the cell (7), riven in the legend to Fig. 3 .
RESULTS AND DISCUSSION
the uptake represents the true Km for the transport of tryptophan. With the miniimal inhibitory concentration of ethambutol (1.0 itg/ml), however, interesting results were observed. Ethambutol inhibited 50% of uptake only in in vitro-grown bacilli and had no significant effect on in vivo-grown bacilli ( Fig.  9 and 10) . Reduction of the respiratory chain between D-lactic dehydrogenase and cytochrome bi is responsible for the efflux of preformed amino acids and sugar pool. Compounds that act before the point of energy coupling block the uptake and do not induce efflux (8, 11) . Ethambutol may be blocking the uptake like the latter compounds. Earlier studies with M. tuberculosis H37Ra (1) (Fig 9) .
Ethambutol probably has no effect on in vivogrown bacilli because of the lack of cytochrome components (13). The chemical composition of in vivo-and in vitro-grown M. tuberculosis have been reviewed recently (10) . The results of the present investigation suggest that ethambutol acts differently in both of the bacilli and also raises the doubt as to how far it is justifiable to use in vitro-grown tubercle bacilli for drug interaction studies. 
